O aprimoramento do tratamento para o linfoma e o aumento da sobrevida suscitam a necessidade de melhoria na qualidade de vida pós cura, o que inclui restrição quanto à toxicidade do tratamento e preocupação quanto ao impacto no futuro reprodutivo.
Referencias bibliográficas
AMZAI, G. et al. Reproductive Issues in Long-Term Surviving Patients following Therapy for Hodgkin’s Disease in the Republic of North Macedonia:...
CICCARONE, M. et al. Effects of ABVD chemotherapy on ovarian function: epidemiology, hormonal dosages and ultrasound morphologic analyses...
HUTCHCRAFT, M. L. et al. Current Fertility Preservation Options for Female Patients With Hodgkin Lymphoma. Obstetrical & Gynecological...
LUONG, S. et al. Chemotherapy alone vs. chemotherapy plus radiotherapy in female adolescent and young adults with Hodgkin’s lymphoma: reproductive...
VIVIANI, S. et al. Male and Female Fertility: Prevention and Monitoring Hodgkin’ Lymphoma and Diffuse Large B-Cell Lymphoma Adult Survivors....